External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients.
Dominik Andreas BarthCarina BrennerJakob Michael RiedlFelix PrinzEva Valentina KlockerKonstantin SchlickPeter KornpratKaroline LacknerHerbert StögerMichael StotzArmin GergerMartin PichlerPublished in: Cancer medicine (2020)
In this large cohort of PC patients, the ALI did not complement existing clinicopathological factors for outcome determination.